why choose us

Clinical Trials Search

Showing 15,840 of 132,963 result(s)
Shockwave, Photobiomodulation, and Physical Therapy for Achilles Tendinopathy

Status: Completed

Condition: Achilles Tendinopathy

Interventions: All participants may complete a PT program as standard of care (SOC) treatment addressing individual strength, mobility, and flexibility deficits in b

Date: 2023-01-27

[18F]PF-06445974 to Image PDE4B in Major Depressive Disorder Using PET

Status: Completed

Condition: Depression

Interventions: Injected IV followed by PET scanning

Date: 2023-01-27

Intervention for Fatigue in HCT Recipients

Status: NOT_YET_RECRUITING

Condition: Hematologic Cancer

Interventions: 10, individualized counseling sessions with a behavioral health counselor via Zoom platform.

Date: 2023-01-27

Study of Efficacy and Safety of Secukinumab in Participants With Moderate-severe Rotator Cuff Tendinopathy

Status: Completed

Condition: Rotator Cuff Tendinopathy

Interventions: The participants will receive Secukinumab 300 mg s.c. at randomization (Baseline visit), Week 1, 2, 3, 4, 8, and 12

Date: 2023-01-27

A Phase 1 Study of SAIL66 in Patients With CLDN6-positive Locally Advanced or Metastatic Solid Tumors

Status: Completed

Condition: Solid Tumor

Interventions: SAIL66 as a IV infusion

Date: 2023-01-27

Survival and Dialysis Independency in Highly Sensitized Patients After Desensitization With Imlifidase and Tx of Kidneys

Status: Completed

Condition: Kidney Transplantation in Highly Sensitized Patients

Interventions: Imlifidase is an immunoglobulin G (IgG)-degrading enzyme of Streptococcus pyogenes that is highly selective towards IgG.
The cleavage of IgG gene

Date: 2023-01-27

Pre-emptive Caudal Epidural Analgesia With Ropivacaine With or Without Dexamethasone in Lumbosacral Spine Surgery

Status: NOT_YET_RECRUITING

Condition: Post Operative Pain

Interventions: Preoperative Ultrasound guided caudal epidural injection in lumbosacral spine surgeries for postoperative analgesia.

Date: 2023-01-27

Tagraxofusp-erzs, an IL-3 Diphtheria Fusion Protein, in Combination With Gemtuzumab Ozogamicin in Patients With Relapsed;Refractory AML

Status: NOT_YET_RECRUITING

Condition: Acute Myeloid Leukemia

Interventions: Sequential dose levels of tagraxofusp-erzs dependent on patient response.
Fixed doses of gemtuzumab ozogamicin 3mg;m2;day on days 1, 4,

Date: 2023-01-27

A Study to Assess the Safety, Tolerability, and Pharmacokinetics of Oral ARN-75039 in Healthy Adult Subjects

Status: Completed

Condition: Lassa Virus Infection

Interventions: SAD: Up to 5 single escalating doses MAD: Up to 3 escalating doses Food-effect: Selected single dose

Date: 2023-01-27

Targeting Breathing Limitations to Improve Functional Outcomes in HFpEF

Status: Completed

Condition: Heart Failure With Preserved Ejection Fraction

Interventions: Low-density helium-oxygen gas mixture (HeO2: 21% O2 and 79% He).
Participant will be breathing this gas mixture.

Date: 2023-01-27